ADIAL PHARMACEUTICALS, INC. - FORM S-1/A - EX-10.27 - AMENDMENT TO CONSULTING AGREEMENT WITH JOSEPH TRULUCK DATED DECEMBER 1, 2018 - April 13, 2018

Attached files

file filename
EX-10.23 - AMENDMENT #5 TO LICENSE AGREEMENT BETWEEN UNIVERSITY OF VIRGINIA PATENT FOUNDATI - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-23_adial.htm
S-1/A - AMENDMENT TO FORM S-1 - ADIAL PHARMACEUTICALS, INC.fs12017a4_adialpharma.htm
EX-23.1 - CONSENT OF FRIEDMAN LLP - ADIAL PHARMACEUTICALS, INC.fs12017a4ex23-1_adial.htm
EX-10.29 - SETTLEMENT AGREEMENT DATED AS OF FEBRUARY 22, 2018 BY AND BETWEEN ADIAL PHARMACE - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-29_adial.htm
EX-10.28 - PERFORMANCE BONUS PLAN CANCELLATION - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-28_adial.htm
EX-10.26 - MEDICAL TRANSLATION SERVICES AGREEMENT BY AND BETWEEN ADIAL PHARMACEUTICALS, INC - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-26_adial.htm
EX-10.25 - BACKSTOP COMMITMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND MVA 151 IN - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-25_adial.htm
EX-10.24 - FORM OF SECURITIES PURCHASE AGREEMENT BY AND AMONG ADIAL PHARMACEUTICALS, INC. A - ADIAL PHARMACEUTICALS, INC.fs12017a4ex10-24_adial.htm
EX-5.1 - OPINION OF GRACIN & MARLOW, LLP - ADIAL PHARMACEUTICALS, INC.fs12017a4ex5-1_adial.htm
EX-4.20(B) - STOCK PURCHASE WARRANT - ADIAL PHARMACEUTICALS, INC.fs12017a4ex4-20b_adial.htm
EX-4.20(A) - STOCK PURCHASE WARRANT - ADIAL PHARMACEUTICALS, INC.fs12017a4ex4-20a_adial.htm
EX-4.19 - SECURITY AGREEMENT - ADIAL PHARMACEUTICALS, INC.fs12017a4ex4-19_adial.htm
EX-4.18 - FORM OF SENIOR SECURED PROMISSORY NOTES DATED MARCH 1, 2018 BY AND BETWEEN ADIAL - ADIAL PHARMACEUTICALS, INC.fs12017a4ex4-18_adial.htm
EX-4.10 - GRANT INCENTIVE PLAN - ADIAL PHARMACEUTICALS, INC.fs12017a4ex4-10_adial.htm

Exhibit 10.27

 

   

1180 Seminole Trail, Suite 495

Charlottesville, VA 22901-5739

+1(434) 422-9800; +1(434) 422-9797 FAX

www.adialpharma.com

 

December 1, 2017

 

Joseph Truluck

1534A Wilhelmina Rise

Honolulu, HI 96816

 

Dear Joe,

 

It is with great pleasure that I congratulate you on your raise to $3,200 per month per our discussions with such raise effective as of December 1, 2017. All other terms of your engagement remain unchanged.

 

Sincerely yours,

 

/s/ William B. Stilley

William B. Stilley

CEO  

ADIAL PHARMACEUTICALS, INC. Reports